KRIBB Scientists Identify SHP Protein As Vital Cartilage Protector In Breakthrough For Osteoarthritis Disease Modification

KRIBB researchers find that the SHP protein prevents cartilage loss by blocking destructive enzymes, offering a new path for osteoarthritis gene therapy.

By: AXL Media

Published: Mar 21, 2026, 7:53 AM EDT

Source: Information for this report was sourced from National Research Council of Science & Technology

Addressing the Root Cause of Joint Degeneration

Osteoarthritis remains one of the most prevalent and debilitating joint disorders globally, particularly among aging populations. While current medical interventions focus almost exclusively on palliative care and pain management, they fail to address the underlying biological mechanisms of cartilage breakdown. A new joint study led by Dr. Chul-Ho Lee and Dr. Yong-Hoon Kim has shifted this focus by identifying the SHP protein as a key regulator of joint health. Published in Nature Communications, the research suggests that maintaining or restoring levels of this protein could serve as a primary defense against the gradual destruction of the cushioning between bones.

The Correlation Between SHP Loss and Disease Severity

The research team began their investigation by analyzing cartilage tissues from both human osteoarthritis patients and specialized animal models. Their findings revealed a direct correlation between the progression of the disease and a significant decrease in SHP protein levels. In experimental models where the SHP protein was entirely absent, subjects experienced accelerated cartilage destruction and heightened pain sensitivity. These observations indicate that the loss of this specific protein is not merely a symptom of the disease, but a functional driver that leaves joints vulnerable to structural failure.

Inhibiting Destructive Enzymatic Pathways

At the molecular level, the study demonstrated for the first time that SHP protects the joint by regulating the IKKβ/NF-κB signaling pathway. This pathway is responsible for the production of matrix-degrading enzymes, specifically MMP-3 and MMP-13, which are the primary agents of cartilage erosion. By inhibiting these enzymes at the source, the SHP protein maintains the integrity of the chondrocytes—the cells responsible for cartilage health. This mechanistic discovery provides a clear target for future pharmacological developments aimed at stopping the enzymatic "digestion" of joint tissue.